APA

Richard N., Salomon H., Rando R., Mansour T., Bowlin T. L. & Wainberg M. A. (20000518). Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. : Antimicrobial agents and chemotherapy.

Chicago

Richard N, Salomon H, Rando R, Mansour T, Bowlin T L and Wainberg M A. 20000518. Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. : Antimicrobial agents and chemotherapy.

Harvard

Richard N., Salomon H., Rando R., Mansour T., Bowlin T. L. and Wainberg M. A. (20000518). Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. : Antimicrobial agents and chemotherapy.

MLA

Richard N, Salomon H, Rando R, Mansour T, Bowlin T L and Wainberg M A. Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. : Antimicrobial agents and chemotherapy. 20000518.